Skip to main content

OCSAW · Oculis Holding AG · Investor Relations

Track OCSAW — free
$2.64 +0.28 (+11.86%) At close · Oct 21
Market Cap
$461.29M
Shares
61.59M
Volume · Oct 21 10.87K Avg daily vol (3M) 5365

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Upcoming events

Date Event Type
2026-10-23 00:00 UTC 10ᵗʰ Joint ACTRIMS-ECTRIMS Meeting Event
2026-11-01 00:00 UTC 6th Asia Pacific Ophthalmic Innovation Society Congress Event
2026-11-03 00:00 UTC Q3-2026 Earnings Release Event
2026-11-05 00:00 UTC Q3-2026 Earnings Release Earnings call

Past events

Date Event Type
2026-10-12 AAO 2026 Event
2026-10-08 Eyecelerator @ AAO 2026 Event
2026-10-04 Euretina Congress Event
2026-09-30 Euretina Innovation Spotlight (EIS) Event
2026-09-25 Leerink Biopharma Summit Event
2026-09-16 HCW Annual Global Investment Conference Conference
2026-09-15 Baird 2026 Global Healthcare Conference Conference
2026-08-30 APVRS 2026 Retina Future Forum Event
2026-08-26 JPM Aspen Summit Event
2026-08-12 Stifel Biotech Summer Summit Event
2026-08-06 Q2-2026 Earnings Release Earnings call
2026-07-14 Ophthalmology Innovation Source (OIS) Annual Retina Innovation Summit Event
2026-07-10 Piper Sandler Virtual Ophthalmology Conference Conference
2026-06-13 Clinical Trials at the Summit Event
2026-06-10 Goldman Sachs 47th Annual Global Healthcare Conference Conference
2026-06-06 European Neuro-Ophthalmology Society Annual Meeting Shareholder meeting
2026-05-29 DIAMOND Phase 3 Topline Results Conference Call Earnings call
2026-05-17 Retina World Congress Event
2026-05-13 2026 Annual General Meeting of Shareholders Shareholder meeting
2026-05-11 Q1-2026 Earnings Release Earnings call
2026-05-11 2026 AGM – Shareholder Information Session Shareholder meeting
2026-05-07 ARVO Annual Meeting Shareholder meeting
2026-05-05 Swiss Biotech Day Event
2026-05-01 Eyecelerator Event
2026-04-22 AAN Annual Meeting Shareholder meeting

Source: https://investors.oculis.com/

Key facts CIK 1953530 CUSIP H5870P102 Visit website Investor relations